Saturday 17 October 2026
Export EMBC’s income statement to Excel — free account
Embecta Corp.
EMBC Healthcare Medical Instruments & Supplies
Embecta Corp.’s revenue for fiscal 2025 (year ended September 2025) was $1.1 billion, down 3.80% from fiscal 2024. In the quarter to June 2026, revenue fell 8.05%, EPS fell 53.9%, free cash flow fell 49.6% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.
6.27
0.18
−2.79%
Follow EMBC
| Sep '25 | Sep '24 | Sep '23 | Sep '22 | Dec '21 | Sep '21 | Dec '20 | Sep '20 | Sep '19 | Sep '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
8.66 | 10.44 | 11.94 | 7.40 | 5.22 | 5.22 | 5.22 | 5.22 | 5.22 | — |
Piotroski F-Score |
7 | 4 | — | — | — | — | — | — | — | — |
Altman Z-Score |
1.84 | 1.36 | 1.55 | 2.14 | — | — | — | — | — | — |
P/S ratio |
0.76 | 0.72 | 0.75 | 1.45 | 2.29 | 2.29 | 2.29 | 2.29 | 2.29 | — |
Altman Z″-Score (non-manufacturers) |
1.99 | 1.20 | 1.49 | 1.91 | — | — | — | — | — | — |
P/FCF ratio |
4.51 | 40.87 | 20.41 | 4.23 | 6.07 | 6.07 | 6.07 | 6.07 | 6.07 | — |
Beneish M-Score |
(3.11) | 7.50 | (2.61) | — | — | — | — | — | — | — |
P/Operating CF |
9.79 | 30.58 | 28.41 | 28.31 | 19.31 | 19.31 | 19.31 | 19.31 | 19.31 | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 4.87 | 4.87 | 4.87 | 4.87 | 4.87 | — |
Dividend Safety Score |
56 | — | — | — | — | — | — | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 5.19 | 5.19 | 5.19 | 5.19 | 5.19 | — |
EV/Sales |
1.87 | 1.91 | 1.92 | 2.61 | 2.29 | 2.29 | 2.29 | 2.29 | 2.29 | — |
EV/EBITDA |
6.69 | 9.92 | 8.25 | 8.57 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | — |
EV/Operating CF |
10.54 | 60.06 | 31.75 | 7.16 | 5.66 | 5.66 | 5.66 | 5.66 | 5.66 | — |
EV/FCF |
11.08 | 107.74 | 52.17 | 7.61 | 6.07 | 6.07 | 6.07 | 6.07 | 6.07 | — |
Quick Ratio |
1.43 | 1.25 | 0.97 | 1.17 | 0.74 | 0.92 | — | 0.88 | — | — |
Current Ratio |
2.41 | 2.03 | 2.12 | 2.21 | 1.62 | 1.78 | — | 1.72 | — | — |
Net Debt/EBITDA |
3.96 | 6.16 | 5.02 | 3.80 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | — |
Debt/Assets |
130.80% | 124.87% | 134.63% | 150.98% | 0.00% | 0.51% | 0.00% | 0.00% | — | 0.00% |
Debt/Equity |
(2.19) | (2.17) | (1.99) | (1.84) | 0.00 | 0.01 | 0.00 | 0.00 | — | — |
Asset Turnover |
0.91 | 0.90 | 0.97 | 1.24 | 0.38 | 2.96 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
2.01 | 0.46 | 0.96 | 1.84 | 1.40 | 1.10 | 1.15 | 1.17 | 1.17 | — |
Capex/Depreciation |
(0.15) | (0.32) | (0.68) | (0.69) | (0.51) | (1.02) | (1.23) | (1.09) | 0.00 | — |
Interest Coverage |
2.26 | 1.49 | 2.07 | 6.70 | — | — | — | — | — | — |
| (13.74%) | (10.04%) | (8.22%) | (131.18%) | 17.26% | 71.13% | 0.00% | 0.00% | 0.00% | — | |
| 8.03% | 6.26% | 6.12% | 24.49% | 12.93% | 105.28% | 0.00% | 0.00% | 0.00% | — | |
ROIC |
27.63% | 17.59% | 28.44% | 46.30% | 13.24% | 51.40% | 0.00% | 6,081.25% | — | — |
Return on Tangible Assets |
15.21% | 11.56% | 10.12% | 33.61% | 18.44% | 71.68% | 0.00% | 75.68% | 0.00% | — |
Average Days of Receivables |
49.19 | 62.72 | 5.44 | 7.17 | 149.26 | 47.17 | 0.00 | 40.35 | 0.00 | — |
Research and Development Expense of Revenue |
3.45% | 7.02% | 7.60% | 5.92% | 5.77% | 5.43% | 4.91% | 5.66% | 5.59% | — |
Selling, General and Administrative Expense of Revenue |
30.73% | 32.51% | 30.45% | 26.10% | 24.40% | 20.62% | 18.65% | 19.78% | 20.02% | — |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | 0.05 | 0.04 | 0.00 | 0.00 | — | 0.00 |
Share Based Compensation of Revenue |
2.92% | 2.34% | 1.92% | 1.66% | 0.00% | 1.10% | 0.00% | 1.17% | 0.00% | — |
Graham Net Nets |
(1.35) | (1.55) | (1.53) | (0.80) | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 44.24 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
11.55% | 9.57% | 8.37% | 13.51% | 19.17% | 19.17% | 19.17% | 19.17% | 19.17% | — |
Free Cash Flow Yield |
22.17% | 2.45% | 4.90% | 23.62% | 16.48% | 16.48% | 16.48% | 16.48% | 16.48% | — |
Revenue per Share |
18.53 | 19.47 | 19.58 | 19.81 | 0.00 | 20.44 | 0.00 | 19.04 | 0.00 | — |
Operating CF per Share |
3.29 | 0.62 | 1.18 | 7.23 | 0.00 | 8.00 | 0.00 | 8.74 | 0.00 | — |
Capex per Share |
(0.16) | (0.27) | (0.46) | (0.42) | 0.00 | (0.69) | 0.00 | (0.73) | — | — |
Free Cash Flow per Share |
3.13 | 0.35 | 0.72 | 6.81 | 0.00 | 7.32 | 0.00 | 8.01 | 0.00 | — |
Cash per Share |
3.92 | 4.75 | 5.70 | 5.80 | — | 0.00 | — | 0.00 | — | — |
Shareholders Equity per Share |
(11.16) | (12.80) | (14.35) | (15.63) | 0.00 | 10.42 | 0.00 | 0.00 | — | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | 0.00 | — | — |
Book value per Share |
(11.16) | (12.80) | (14.35) | (15.63) | 0.00 | 10.42 | 0.00 | 0.00 | — | — |
Free Cash Flow |
182.40 | 19.90 | 41.20 | 388.20 | 134.50 | 417.10 | 110.00 | 456.60 | 505.00 | — |
Working Capital |
369.90 | 387.00 | 395.60 | 363.70 | 99.20 | 127.80 | — | 98.00 | — | — |
Capital Expenditures |
(9.30) | (15.80) | (26.50) | (24.00) | (4.30) | (39.20) | (11.40) | (41.90) | (69.00) | — |
Net Current Asset Value |
(1,110.10) | (1,262.60) | (1,287.00) | (1,313.10) | 68.90 | 98.10 | 0.00 | 235.00 | — | — |
EV/EBIT |
8.35 | 12.85 | 9.70 | 9.53 | 5.53 | 5.53 | 5.53 | 5.53 | 5.53 | — |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.03 | 0.04 | 0.04 | 0.00 | — |
Price to Operating Income |
3.40 | 4.88 | 3.80 | 5.30 | 5.53 | 5.53 | 5.53 | 5.53 | 5.53 | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.23 | 0.17 | 0.13 | 0.12 | 0.02 | 0.08 | 0.00 | 0.08 | 0.00 | — |
Cash ROIC |
18.15% | 1.74% | 3.61% | 35.95% | 24.43% | 69.71% | 0.00% | 9,132.00% | 0.00% | — |
Accounts Receivable Turnover |
6.38 | 10.71 | 57.62 | 16.08 | 2.15 | 8.61 | 0.00 | 0.00 | 0.00 | — |
Accounts Payable Turnover |
4.89 | 5.37 | 7.82 | 7.13 | 1.52 | 7.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
2.31 | 2.40 | 2.70 | 2.93 | 0.72 | 3.32 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
67.10 | 85.63 | 52.65 | 42.61 | 248.32 | 54.21 | 0.00 | 56.52 | 0.00 | — |
Days of Inventory on Hand |
161.52 | 161.38 | 149.68 | 126.40 | 509.03 | 118.03 | 0.00 | 115.30 | 0.00 | — |
Average Receivables |
169.30 | 104.85 | 19.45 | 70.25 | 134.45 | 135.30 | — | — | — | — |
Average Payables |
82.60 | 72.25 | 47.45 | 49.75 | 56.15 | 52.10 | — | — | — | — |
Average Inventory |
175.05 | 161.80 | 137.45 | 120.95 | 118.55 | 110.00 | — | — | — | — |
Average Assets |
1,188.10 | 1,249.85 | 1,150.40 | 913.15 | 763.95 | 394.00 | 0.00 | 0.00 | — | — |
Average Common Equity |
(694.45) | (780.00) | (856.55) | (170.45) | 572.40 | 583.15 | — | — | — | — |
Columns are period end dates